Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 107

1.

"A Natural Progression": Australian Women's Attitudes About an Individualized Breast Screening Model.

Lippey J, Keogh LA, Mann GB, Campbell IG, Forrest LE.

Cancer Prev Res (Phila). 2019 Jun;12(6):383-390. doi: 10.1158/1940-6207.CAPR-18-0443. Epub 2019 Apr 19.

PMID:
31003994
2.

Experiences and interpretations of BRCA1/2 testing among women affected by breast or ovarian cancer who received a negative result.

Stafford L, Flehr A, Judd F, Lindeman GJ, Gibson P, Komiti A, Mann GB, Kentwell M.

J Community Genet. 2019 Mar 27. doi: 10.1007/s12687-019-00415-w. [Epub ahead of print]

PMID:
30919324
3.

Valuing the health states associated with breast cancer screening programmes: A systematic review of economic measures.

Bromley HL, Petrie D, Mann GB, Nickson C, Rea D, Roberts TE.

Soc Sci Med. 2019 May;228:142-154. doi: 10.1016/j.socscimed.2019.03.028. Epub 2019 Mar 21. Review.

PMID:
30913528
4.

Atypical ductal hyperplasia is a multipotent precursor of breast carcinoma.

Kader T, Hill P, Zethoven M, Goode DL, Elder K, Thio N, Doyle M, Semple T, Sufyan W, Byrne DJ, Pang JB, Murugasu A, Miligy IM, Green AR, Rakha EA, Fox SB, Mann GB, Campbell IG, Gorringe KL.

J Pathol. 2019 Jul;248(3):326-338. doi: 10.1002/path.5262. Epub 2019 Apr 22.

PMID:
30843206
5.

Molecular comparison of interval and screen-detected breast cancers.

Cheasley D, Li N, Rowley SM, Elder K, Mann GB, Loi S, Savas P, Goode DL, Kader T, Zethoven M, Semple T, Fox SB, Pang JM, Byrne D, Devereux L, Nickson C, Procopio P, Lee G, Hughes S, Saunders H, Fujihara KM, Kuykhoven K, Connaughton J, James PA, Gorringe KL, Campbell IG.

J Pathol. 2019 Jun;248(2):243-252. doi: 10.1002/path.5251. Epub 2019 Mar 8.

PMID:
30746706
6.

The iPrevent Online Breast Cancer Risk Assessment and Risk Management Tool: Usability and Acceptability Testing.

Lo LL, Collins IM, Bressel M, Butow P, Emery J, Keogh L, Weideman P, Steel E, Hopper JL, Trainer AH, Mann GB, Bickerstaffe A, Antoniou AC, Cuzick J, Phillips KA.

JMIR Form Res. 2018 Nov 7;2(2):e24. doi: 10.2196/formative.9935.

7.

Prospective validation of the NCI Breast Cancer Risk Assessment Tool (Gail Model) on 40,000 Australian women.

Nickson C, Procopio P, Velentzis LS, Carr S, Devereux L, Mann GB, James P, Lee G, Wellard C, Campbell I.

Breast Cancer Res. 2018 Dec 20;20(1):155. doi: 10.1186/s13058-018-1084-x.

8.

Treatment Intensity Differences According to Participation in a Population Screening Program.

Mann GB, Nickson C, Elder K.

Ann Surg Oncol. 2019 Feb;26(2):698-699. doi: 10.1245/s10434-018-07113-w. Epub 2018 Dec 18. No abstract available.

PMID:
30565041
9.

A Phase Ib Dose-Escalation and Expansion Study of the BCL2 Inhibitor Venetoclax Combined with Tamoxifen in ER and BCL2-Positive Metastatic Breast Cancer.

Lok SW, Whittle JR, Vaillant F, Teh CE, Lo LL, Policheni AN, Bergin ART, Desai J, Ftouni S, Gandolfo LC, Liew D, Liu HK, Mann GB, Moodie K, Murugasu A, Pal B, Roberts AW, Rosenthal MA, Shackleton K, Silva MJ, Siow ZR, Smyth GK, Taylor L, Travers A, Yeo B, Yeung MM, Bujak AZ, Dawson SJ, Gray DHD, Visvader JE, Lindeman GJ.

Cancer Discov. 2019 Mar;9(3):354-369. doi: 10.1158/2159-8290.CD-18-1151. Epub 2018 Dec 5.

PMID:
30518523
10.

Consumer and clinician perspectives on personalising breast cancer prevention information.

Keogh LA, Steel E, Weideman P, Butow P, Collins IM, Emery JD, Mann GB, Bickerstaffe A, Trainer AH, Hopper LJ, Phillips KA.

Breast. 2019 Feb;43:39-47. doi: 10.1016/j.breast.2018.11.002. Epub 2018 Nov 7.

PMID:
30445378
11.

ASO Author Reflections: Impact of Breast Cancer Screening Beyond Mortality Reductions.

Elder K, Nickson C, Mann GB.

Ann Surg Oncol. 2018 Dec;25(Suppl 3):687-688. doi: 10.1245/s10434-018-7001-9. Epub 2018 Nov 9. No abstract available.

PMID:
30414033
12.

The impact and indications for Oncotype DX on adjuvant treatment recommendations when third-party funding is unavailable.

Chin-Lenn L, De Boer RH, Segelov E, Marx GM, Hughes TM, McCarthy NJ, White SC, Foo SS, Rutovitz JJ, Della-Fiorentina S, Jennens R, Antill YC, Tsoi D, Cronk MF, Lombard JM, Kiely BE, Chirgwin JH, Gorelik A, Mann GB.

Asia Pac J Clin Oncol. 2018 Dec;14(6):410-416. doi: 10.1111/ajco.13075. Epub 2018 Sep 30.

PMID:
30270527
13.

Factors influencing reoperation following breast-conserving surgery.

Philpott A, Wong J, Elder K, Gorelik A, Mann GB, Skandarajah A.

ANZ J Surg. 2018 Sep;88(9):922-927. doi: 10.1111/ans.14467. Epub 2018 May 15.

PMID:
29763991
14.

Spotlight on the utility of the Oncotype DX® breast cancer assay.

Siow ZR, De Boer RH, Lindeman GJ, Mann GB.

Int J Womens Health. 2018 Feb 21;10:89-100. doi: 10.2147/IJWH.S124520. eCollection 2018. Review.

15.

Uptake of adjuvant breast cancer treatments recommended by multi-disciplinary meetings.

Pattanasri M, Elder K, Nickson C, Cooke S, Machalek D, Rose A, Mou A, Collins JP, Park A, De Boer R, Phillips C, Pridmore V, Farrugia H, Mann GB.

ANZ J Surg. 2018 Jan 23. doi: 10.1111/ans.14368. [Epub ahead of print]

PMID:
29363225
16.

Study protocol for Enhancing Parenting In Cancer (EPIC): development and evaluation of a brief psycho-educational intervention to support parents with cancer who have young children.

Stafford L, Sinclair M, Turner J, Newman L, Wakefield C, Krishnasamy M, Mann GB, Gilham L, Mason K, Rauch P, Cannell J, Schofield P.

Pilot Feasibility Stud. 2017 Dec 11;3:72. doi: 10.1186/s40814-017-0215-y. eCollection 2017.

17.

Relationship of the Breast Ductal Carcinoma In Situ Immune Microenvironment with Clinicopathological and Genetic Features.

Hendry S, Pang JB, Byrne DJ, Lakhani SR, Cummings MC, Campbell IG, Mann GB, Gorringe KL, Fox SB.

Clin Cancer Res. 2017 Sep 1;23(17):5210-5217. doi: 10.1158/1078-0432.CCR-17-0743. Epub 2017 Jun 13.

18.

Erratum to: Methods for evaluating medical tests and biomarkers.

Gopalakrishna G, Langendam M, Scholten R, Bossuyt P, Leeflang M, Noel-Storr A, Thomas J, Marshall I, Wallace B, Whiting P, Davenport C, Leeflang M, GopalaKrishna G, de Salis I, Mallett S, Wolff R, Whiting P, Riley R, Westwood M, Kleinen J, Collins G, Reitsma H, Moons K, Zapf A, Hoyer A, Kramer K, Kuss O, Ensor J, Deeks JJ, Martin EC, Riley RD, Rücker G, Steinhauser S, Schumacher M, Riley R, Ensor J, Snell K, Willis B, Debray T, Moons K, Deeks J, Collins G, di Ruffano LF, Willis B, Davenport C, Mallett S, Taylor-Phillips S, Hyde C, Deeks J, Mallett S, Taylor SA, Batnagar G; STREAMLINE COLON Investigators; STREAMLINE LUNG Investigators; METRIC Investigators, Taylor-Phillips S, Di Ruffano LF, Seedat F, Clarke A, Deeks J, Byron S, Nixon F, Albrow R, Walker T, Deakin C, Hyde C, Zhelev Z, Hunt H, di Ruffano LF, Yang Y, Abel L, Buchanan J, Fanshawe T, Shinkins B, Wynants L, Verbakel J, Van Huffel S, Timmerman D, Van Calster B, Leeflang M, Zwinderman A, Bossuyt P, Oke J, O'Sullivan J, Perera R, Nicholson B, Bromley HL, Roberts TE, Francis A, Petrie D, Mann GB, Malottki K, Smith H, Deeks J, Billingham L, Sitch A, Mallett S, Deeks J, Gerke O, Holm-Vilstrup M, Segtnan EA, Halekoh U, Høilund-Carlsen PF, Francq BG, Deeks J, Sitch A, Dinnes J, Parkes J, Gregory W, Hewison J, Altman D, Rosenberg W, Selby P, Asselineau J, Perez P, Paye A, Bessede E, Proust-Lima C, Naaktgeboren C, de Groot J, Rutjes A, Bossuyt P, Reitsma J, Moons K, Collins G, Ogundimu E, Cook J, Le Manach Y, Altman D, Wynants L, Vergouwe Y, Van Huffel S, Timmerman D, Van Calster B, Pajouheshnia R, Groenwold R, Moons K, Reitsma J, Peelen L, Van Calster B, Nieboer D, Vergouwe Y, De Cock B, Pencina MJ, Steyerberg EW, Cooper J, Taylor-Phillips S, Parsons N, Stinton C, Smith S, Dickens A, Jordan R, Enocson A, Fitzmaurice D, Sitch A, Adab P, Francq BG, Boachie C, Vidmar G, Freeman K, Connock M, Taylor-Phillips S, Court R, Clarke A, de Groot J, Naaktgeboren C, Reitsma H, Moons C, Harris J, Mumford A, Plummer Z, Lee K, Reeves B, Rogers C, Verheyden V, Angelini GD, Murphy GJ, Huddy J, Ni M, Good K, Cooke G, Bossuyt P, Hanna G, Ma J, Altman D, Collins G, Moons KGMC, de Groot JAH, Mallett S, Altman DG, Reitsma JB, Collins GS, Moons KGM, Altman DG, Reitsma JB, Collins GS, Kamarudin AN, Kolamunnage-Dona R, Cox T, Ni M, Huddy J, Borsci S, Hanna G, Pérez T, Pardo MC, Candela-Toha A, Muriel A, Zamora J, Sanghera S, Mohiuddin S, Martin R, Donovan J, Coast J, Seo MK, Cairns J, Mitchell E, Smith A, Wright J, Hall P, Messenger M, Calder N, Wickramasekera N, Vinall-Collier K, Lewington A, Pajouheshnia R, Damen J, Groenwold R, Moons K, Peelen L, Messenger M, Cairns D, Smith A, Hutchinson M, Wright J, Hall P, Calder N, Sturgeon C, Mitchel L, Kift R, Christakoudi S, Rungall M, Mobillo P, Montero R, Tsui TL, Kon SP, Tucker B, Sacks S, Farmer C, Strom T, Chowdhury P, Rebollo-Mesa I, Hernandez-Fuentes M, Damen JAAG, Debray TPA, Heus P, Hooft L, Moons KGM, Pajouheshnia R, Reitsma JB, Scholten RJPM, Damen JAAG, Hooft L, Schuit E, Debray TPA, Collins GS, Tzoulaki I, Lassale CM, Siontis GCM, Chiocchia V, Roberts C, Schlüssel MM, Gerry S, Black JA, Heus P, van der Schouw YT, Peelen LM, Moons KGM, Damen JAAG, Debray TPA, Heus P, Hooft L, Moons KGM, Pajouheshnia R, Reitsma JB, Scholten RJPM, Ma J, Altman D, Collins G, Spence G, McCartney D, van den Bruel A, Lasserson D, Hayward G, Vach W, de Jong A, Burggraaff C, Hoekstra O, Zijlstra J, de Vet H, Hunt H, Hyde C, Graziadio S, Allen J, Johnston L, O'Leary R, Power M, Allen J, Graziadio S, Johnson L, O'Leary R, Power M, Waters R, Simpson J, Johnston L, Allen J, Graziadio S, O'Leary R, Waters R, Power M, Mallett S, Fanshawe TR, Phillips P, Plumb A, Helbren E, Halligan S, Taylor SA, Gale A, Mallett S, Sekula P, Altman DG, Sauerbrei W, Mallett S, Fanshawe TR, Forman JR, Dutton SJ, Takwoingi Y, Hensor EM, Nichols TE, Shinkins B, Yang Y, Abel L, Di Ruffano LF, Fanshawe T, Kempf E, Porcher R, de Beyer J, Moons K, Altman D, Reitsma H, Hopewell S, Sauerbrei W, Collins G, Dennis J, Shields B, Jones A, Henley W, Pearson E, Hattersley A; MASTERMIND consortium, Heus P, Damen JAAG, Pajouheshnia R, Scholten RJPM, Reitsma JB, Collins GS, Altman DG, Moons KGM, Hooft L, Shields B, Dennis J, Jones A, Henley W, Pearson E, Hattersley A; MASTERMIND consortium, Scheibler F, Rummer A, Sturtz S, Großelfinger R, Banister K, Ramsay C, Azuara-Blanco A, Cook J, Boachie C, Burr J, Kumarasamy M, Bourne R, Uchegbu I, Borsci S, Murphy J, Hanna G, Uchegbu I, Carter A, Murphy J, Ni M, Marti J, Eatock J, Uchegbu I, Robotham J, Dudareva M, Gilchrist M, Holmes A, Uchegbu I, Borsci S, Monaghan P, Lord S, StJohn A, Sandberg S, Cobbaert C, Lennartz L, Verhagen-Kamerbeek W, Ebert C, Bossuyt P, Horvath A; Test Evaluation Working Group of the European Federation of Clinical Chemistry and Laboratory Medicine, Jenniskens K, Naaktgeboren C, Reitsma J, Moons K, de Groot J, Hyde C, Peters J, Grigore B, Peters J, Hyde C, Hyde C, Ukoumunne O, Peters J, Zhelev Z, Levis B, Benedetti A, Levis AW, Ioannidis JPA, Shrier I, Cuijpers P, Gilbody S, Kloda LA, McMillan D, Patten SB, Steele RJ, Ziegelstein RC, Bombardier CH, Osório FL, Fann JR, Gjerdingen D, Lamers F, Lotrakul M, Loureiro SR, Löwe B, Shaaban J, Stafford L, van Weert HCPM, Whooley MA, Williams LS, Wittkampf KA, Yeung AS, Thombs BD, Peters J, Cooper C, Buchanan J, Nieto T, Smith C, Tucker O, Dretzke J, Beggs A, Rai N, Davenport C, Bayliss S, Stevens S, Snell K, Mallet S, Deeks J, Sundar S, Hall E, Porta N, Estelles DL, de Bono J; CTC-STOP protocol development group.

Diagn Progn Res. 2017 Mar 30;1:11. doi: 10.1186/s41512-017-0011-4. eCollection 2017.

19.

Breast ductal carcinoma in situ carry mutational driver events representative of invasive breast cancer.

Pang JB, Savas P, Fellowes AP, Mir Arnau G, Kader T, Vedururu R, Hewitt C, Takano EA, Byrne DJ, Choong DY, Millar EK, Lee CS, O'Toole SA, Lakhani SR, Cummings MC, Mann GB, Campbell IG, Dobrovic A, Loi S, Gorringe KL, Fox SB.

Mod Pathol. 2017 Jul;30(7):952-963. doi: 10.1038/modpathol.2017.21. Epub 2017 Mar 24.

20.

Surgeon knows best versus breast cancer surgical clinical trial equipoise: a plea for the sake of future trials.

Spillane AJ, Mann GB.

ANZ J Surg. 2017 Mar;87(3):111-112. doi: 10.1111/ans.13831. No abstract available.

PMID:
28253558
21.

Patient and medical barriers preclude uptake of tamoxifen preventative therapy in women with a strong family history.

Skandarajah AR, Thomas S, Shackleton K, Chin-Lenn L, Lindeman GJ, Mann GB.

Breast. 2017 Apr;32:93-97. doi: 10.1016/j.breast.2017.01.002. Epub 2017 Jan 18.

PMID:
28107734
22.

Patient-reported outcomes in ductal carcinoma in situ: A systematic review.

King MT, Winters ZE, Olivotto IA, Spillane AJ, Chua BH, Saunders C, Westenberg AH, Mann GB, Burnett P, Butow P, Rutherford C.

Eur J Cancer. 2017 Jan;71:95-108. doi: 10.1016/j.ejca.2016.09.035. Epub 2016 Dec 15. Review.

PMID:
27987454
23.

Laparoscopic or open appendicectomy for suspected appendicitis in pregnancy and evaluation of foetal outcome in Australia.

Winter NN, Guest GD, Bozin M, Thomson BN, Mann GB, Tan SBM, Clark DA, Daruwalla J, Muralidharan V, Najan N, Pitcher ME, Vilhelm K, Cox MR, Lane SE, Watters DA.

ANZ J Surg. 2017 May;87(5):334-338. doi: 10.1111/ans.13750. Epub 2016 Sep 6.

PMID:
27598241
24.

RANK ligand as a potential target for breast cancer prevention in BRCA1-mutation carriers.

Nolan E, Vaillant F, Branstetter D, Pal B, Giner G, Whitehead L, Lok SW, Mann GB; Kathleen Cuningham Foundation Consortium for Research into Familial Breast Cancer (kConFab), Rohrbach K, Huang LY, Soriano R, Smyth GK, Dougall WC, Visvader JE, Lindeman GJ.

Nat Med. 2016 Aug;22(8):933-9. doi: 10.1038/nm.4118. Epub 2016 Jun 20.

PMID:
27322743
25.

Management of Early Node-Positive Breast Cancer in Australia: A Multicentre Study.

Gannan E, Khoo J, Nightingale S, Suhardja TS, Lippey J, Keane H, Tan KJ, Clouston D, Gorelik A, Mann GB; Melbourne Breast Group.

Breast J. 2016 Jul;22(4):413-9. doi: 10.1111/tbj.12595. Epub 2016 Apr 20.

PMID:
27095381
26.

Predictors of depression and anxiety symptom trajectories in the 24 months following diagnosis of breast or gynaecologic cancer.

Stafford L, Komiti A, Bousman C, Judd F, Gibson P, Mann GB, Quinn M.

Breast. 2016 Apr;26:100-5. doi: 10.1016/j.breast.2016.01.008. Epub 2016 Feb 17.

PMID:
27017248
27.

A survey of Australian and New Zealand clinical practice with neoadjuvant systemic therapy for breast cancer.

Zdenkowski N, Butow P, Mann GB, Fewster S, Beckmore C, Isaacs R, Douglas C, Boyle FM.

Intern Med J. 2016 Jun;46(6):677-83. doi: 10.1111/imj.13049.

PMID:
26929045
28.

iPrevent®: a tailored, web-based, decision support tool for breast cancer risk assessment and management.

Collins IM, Bickerstaffe A, Ranaweera T, Maddumarachchi S, Keogh L, Emery J, Mann GB, Butow P, Weideman P, Steel E, Trainer A, Bressel M, Hopper JL, Cuzick J, Antoniou AC, Phillips KA.

Breast Cancer Res Treat. 2016 Feb;156(1):171-82. doi: 10.1007/s10549-016-3726-y. Epub 2016 Feb 24.

29.

Observation versus late reintroduction of letrozole as adjuvant endocrine therapy for hormone receptor-positive breast cancer (ANZ0501 LATER): an open-label randomised, controlled trial.

Zdenkowski N, Forbes JF, Boyle FM, Kannourakis G, Gill PG, Bayliss E, Saunders C, Della-Fiorentina S, Kling N, Campbell I, Mann GB, Coates AS, Gebski V, Davies L, Thornton R, Reaby L, Cuzick J, Green M; Australia and New Zealand Breast Cancer Trials Group.

Ann Oncol. 2016 May;27(5):806-12. doi: 10.1093/annonc/mdw055. Epub 2016 Feb 9.

PMID:
26861603
30.

Copy number analysis of ductal carcinoma in situ with and without recurrence.

Gorringe KL, Hunter SM, Pang JM, Opeskin K, Hill P, Rowley SM, Choong DY, Thompson ER, Dobrovic A, Fox SB, Mann GB, Campbell IG.

Mod Pathol. 2015 Sep;28(9):1174-84. doi: 10.1038/modpathol.2015.75. Epub 2015 Jun 19.

31.

Solitary pituitary metastasis from HER2-positive breast cancer.

Kam J, Kam J, Mann GB, Phillips C, Wentworth JM, King J, Lindeman GJ.

Asia Pac J Clin Oncol. 2017 Apr;13(2):e181-e184. doi: 10.1111/ajco.12353. Epub 2015 Apr 14.

PMID:
25869477
32.

Transitioning to routine breast cancer risk assessment and management in primary care: what can we learn from cardiovascular disease?

Phillips KA, Steel EJ, Collins I, Emery J, Pirotta M, Mann GB, Butow P, Hopper JL, Trainer A, Moreton J, Antoniou AC, Cuzick J, Keogh L.

Aust J Prim Health. 2016;22(3):255-261. doi: 10.1071/PY14156.

PMID:
25705982
33.

Anxiety and depression symptoms in the 2 years following diagnosis of breast or gynaecologic cancer: prevalence, course and determinants of outcome.

Stafford L, Judd F, Gibson P, Komiti A, Mann GB, Quinn M.

Support Care Cancer. 2015 Aug;23(8):2215-24. doi: 10.1007/s00520-014-2571-y. Epub 2015 Jan 6.

PMID:
25559036
34.

Predictors of outcome after surgery for gastric cancer in a Western cohort.

Pattison S, Mann GB, Crosthwaite G, Lade S, Mitchell C, Leong T, Busuttil RA, Boussioutas A.

ANZ J Surg. 2016 Jun;86(6):469-74. doi: 10.1111/ans.12915. Epub 2014 Nov 12.

PMID:
25388659
35.

Status of sentinel node biopsy - response.

Mann GB.

Surgeon. 2015 Feb;13(1):60. doi: 10.1016/j.surge.2014.06.011. Epub 2014 Aug 1. No abstract available.

PMID:
25087503
36.

Assessing and managing breast cancer risk: clinicians' current practice and future needs.

Collins IM, Steel E, Mann GB, Emery JD, Bickerstaffe A, Trainer A, Butow P, Pirotta M, Antoniou AC, Cuzick J, Hopper J, Phillips KA, Keogh LA.

Breast. 2014 Oct;23(5):644-50. doi: 10.1016/j.breast.2014.06.014. Epub 2014 Jul 4.

PMID:
24998452
37.

Sentinel node biopsy in breast cancer revisited.

Omair M, Al-Azawi D, Mann GB.

Surgeon. 2014 Jun;12(3):158-65. doi: 10.1016/j.surge.2013.12.007. Epub 2014 Feb 16. Review.

PMID:
24548701
38.

Comparison of outcomes after laparoscopic versus posterior retroperitoneoscopic adrenalectomy: a pilot study.

Cabalag MS, Mann GB, Gorelik A, Miller JA.

Surg Laparosc Endosc Percutan Tech. 2014 Feb;24(1):62-6. doi: 10.1097/SLE.0b013e31828fa71f.

PMID:
24487160
39.

Posterior retroperitoneoscopic adrenalectomy: outcomes and lessons learned from initial 50 cases.

Cabalag MS, Mann GB, Gorelik A, Miller JA.

ANZ J Surg. 2015 Jun;85(6):478-82. doi: 10.1111/ans.12508. Epub 2014 Jan 20.

PMID:
24438017
40.

Women's reflections on fertility and motherhood after breast cancer and its treatment.

Kirkman M, Winship I, Stern C, Neil S, Mann GB, Fisher JR.

Eur J Cancer Care (Engl). 2014 Jul;23(4):502-13. doi: 10.1111/ecc.12163. Epub 2014 Jan 14.

PMID:
24417674
41.

Comparison of the hospital anxiety and depression scale and the center for epidemiological studies depression scale for detecting depression in women with breast or gynecologic cancer.

Stafford L, Judd F, Gibson P, Komiti A, Quinn M, Mann GB.

Gen Hosp Psychiatry. 2014 Jan-Feb;36(1):74-80. doi: 10.1016/j.genhosppsych.2013.08.010. Epub 2013 Nov 5.

PMID:
24200105
42.

The impact of a genomic assay (Oncotype DX) on adjuvant treatment recommendations in early breast cancer.

de Boer RH, Baker C, Speakman D, Chao CY, Yoshizawa C, Mann GB.

Med J Aust. 2013 Aug 5;199(3):205-8.

PMID:
23909545
43.

Five-year analysis of magnetic resonance imaging as a screening tool in women at hereditary risk of breast cancer.

Kam JK, Naidu P, Rose AK, Mann GB.

J Med Imaging Radiat Oncol. 2013 Aug;57(4):400-6. doi: 10.1111/1754-9485.12030. Epub 2013 Jan 14.

PMID:
23870334
44.

Targeting BCL-2 with the BH3 mimetic ABT-199 in estrogen receptor-positive breast cancer.

Vaillant F, Merino D, Lee L, Breslin K, Pal B, Ritchie ME, Smyth GK, Christie M, Phillipson LJ, Burns CJ, Mann GB, Visvader JE, Lindeman GJ.

Cancer Cell. 2013 Jul 8;24(1):120-9. doi: 10.1016/j.ccr.2013.06.002.

45.

Profile and predictors of long-term morbidity in breast cancer survivors.

Tian Y, Schofield PE, Gough K, Mann GB.

Ann Surg Oncol. 2013 Oct;20(11):3453-60. doi: 10.1245/s10434-013-3004-8. Epub 2013 May 24.

PMID:
23702642
46.

Improving the impact of didactic resident training with online spaced education.

Gyorki DE, Shaw T, Nicholson J, Baker C, Pitcher M, Skandarajah A, Segelov E, Mann GB.

ANZ J Surg. 2013 Jun;83(6):477-80. doi: 10.1111/ans.12166. Epub 2013 Apr 26.

PMID:
23617607
47.

Signaling for lymphangiogenesis via VEGFR-3 is required for the early events of metastasis.

Matsumoto M, Roufail S, Inder R, Caesar C, Karnezis T, Shayan R, Farnsworth RH, Sato T, Achen MG, Mann GB, Stacker SA.

Clin Exp Metastasis. 2013 Aug;30(6):819-32. doi: 10.1007/s10585-013-9581-x. Epub 2013 Apr 17.

PMID:
23591595
48.

Which sentinel lymph-node (SLN) positive breast cancer patient needs an axillary lymph-node dissection (ALND)--ACOSOG Z0011 results and beyond.

Gatzemeier W, Mann GB.

Breast. 2013 Jun;22(3):211-6. doi: 10.1016/j.breast.2013.02.001. Epub 2013 Mar 9. Review.

PMID:
23478200
49.

Screening for depression and anxiety in women with breast and gynaecologic cancer: course and prevalence of morbidity over 12 months.

Stafford L, Judd F, Gibson P, Komiti A, Mann GB, Quinn M.

Psychooncology. 2013 Sep;22(9):2071-8. doi: 10.1002/pon.3253. Epub 2013 Feb 12.

PMID:
23401315
50.

Fertility management after breast cancer diagnosis: a qualitative investigation of women's experiences of and recommendations for professional care.

Kirkman M, Stern C, Neil S, Winship I, Mann GB, Shanahan K, Missen D, Shepherd H, Fisher JR.

Health Care Women Int. 2013;34(1):50-67. doi: 10.1080/07399332.2012.735729.

PMID:
23216096

Supplemental Content

Support Center